# Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety

> **NCT06894836** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Orygen** · enrollment: 75 (estimated)

## Conditions studied

- Depression Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Third wave VR therapy

## Key facts

- **NCT ID:** NCT06894836
- **Lead sponsor:** Orygen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06894836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06894836, "Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06894836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*